Skip to main content
DongKookPharmaceuticalCo.,Ltd. logo

DongKookPharmaceuticalCo.,Ltd. — Investor Relations & Filings

Ticker · 086450 ISIN · KR7086450004 KO Manufacturing
Open in API
Filings indexed 159 across all filing types
Latest filing 2021-09-16 Regulatory Filings
Country KR South Korea
Listing KO 086450

About DongKookPharmaceuticalCo.,Ltd.

https://www.dkpharm.co.kr/en/

DongKook Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of medical products. Established in 1968, the company focuses on improving human health and quality of life. Its product portfolio includes prescription and non-prescription drugs, with key therapeutic areas in anesthetics, contrast media, anti-cancer agents, antibiotics, and oral healthcare treatments. The company operates its own Active Pharmaceutical Ingredient (API) synthesis facilities and invests in research and development to create innovative therapeutic solutions. It provides both finished products and raw materials to domestic and international markets.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약해지(자율공시)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding the termination of a supply contract by Dongkook Pharmaceutical. It details the contract cancellation, the reasons for termination, and the financial impact. Since it is a specific regulatory disclosure regarding a business contract event that does not fit into categories like M&A, dividends, or share issues, it is classified as a general regulatory filing.
2021-09-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required by the Financial Services Commission and Korea Exchange when an entity acquires a significant stake (typically 5% or more) in a listed company. This document details the shareholding status, changes in ownership, and the purpose of the investment (in this case, simple investment). It is a standard regulatory disclosure form, not an annual report, earnings release, or announcement of a report.
2021-08-31 Korean
반기보고서 (2021.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-annual Report) for Dongkook Pharmaceutical Co., Ltd. for the period ending June 30, 2021. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2021
2021-08-17 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for DongKook Pharmaceutical Co., Ltd. for the first quarter of 2021 (2021.01.01-2021.03.31). It contains detailed financial statements, management analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-14 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results of an Annual General Meeting (AGM) for Dongkook Pharmaceutical. It details the outcomes of shareholder votes, including the approval of financial statements, dividend declarations, and the election of directors. This aligns perfectly with the definition of a Declaration of Voting Results (DVA).
2021-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Dongkook Pharmaceutical titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/proper), key financial data (assets, liabilities, revenue, profit), and details regarding the auditor (Samduk Accounting Corp). While it contains financial data, it is a formal notification of the audit report's completion and submission to the regulatory body, rather than the full annual report itself. Therefore, it is classified as an Audit Report / Information document. FY 2020
2021-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.